Question follow-through · 382
Wheelchairs: Procurement
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the provision of NHS wheelchair services by AJM Healthcare.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 17 Jul 2024
- Target answer date
- 22 Jul 2024
- Answer
- 23 Jul 2024 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Congenital Disorder of Glycosylation · 18 Jul 2024
- Congenital Disorder of Glycosylation · 18 Jul 2024
- Coronavirus: Medical Treatments · 22 Jul 2024
- Hospitals: Planning Permission · 30 Jul 2024
- AJM Healthcare: Wheelchairs · 30 Jul 2024
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
17 Jul 2024
Question tabled
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the provision of NHS wheelchair services by AJM Healthcare.
22 Jul 2024
Target answer date
Date supplied by the official written-questions record.
23 Jul 2024
Answer published
Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchairs services. It is therefore the responsibility of ICBs to review and assess the quality of the provision of their commissioned National Health Service whe...
Official data retrieved 27 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Congenital Disorder of Glycosylation
18 Jul 2024 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of including a dedicated Congenital Disorders of Glycosylation section in the UK Strategy for Rare Diseases.
Congenital Disorder of Glycosylation
18 Jul 2024 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of establishing a national patient register for Congenital Disorders of Glycosylation.
Coronavirus: Medical Treatments
22 Jul 2024 · To ask the Secretary of State for Health and Social Care, if he will take steps to reinstate the Covid Medicines Delivery Unit to provide access to antiviral drugs for people with covid-19 infections who are clinically vulnerable.
Hospitals: Planning Permission
30 Jul 2024 · To ask the Secretary of State for Health and Social Care, how many of the new hospitals in the New Hospital Programme have planning permission.
AJM Healthcare: Wheelchairs
30 Jul 2024 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 July to Question 383 on Wheelchairs: Procurement, if he will take steps to solicit feedback from ICBs on the performance of AJM Healthcare in their areas.
Trastuzumab Deruxtecan
30 Aug 2024 · To ask the Secretary of State for Health and Social Care, if he will make representations to (a) Daiichi Sankyo and (b) AstraZeneca following the decision by NICE not to recommend Enhertu as a cost effective treatment for advanced stage breast cancer.
Coronavirus: Vaccination
2 Sept 2024 · To ask the Secretary of State for Health and Social Care, if he will make it his policy to extend the covid-19 booster vaccination this autumn to (a) unpaid and (b) young carers.
Cancer: Medical Treatments
2 Sept 2024 · To ask the Secretary of State for Health and Social Care, whether he (a) has had and (b) plans to have discussions with the National Institute for Health and Care Excellence on (i) its use of the new severity modifier and (ii) how it (A) measures and (B)
Cancer: Medical Treatments
2 Sept 2024 · To ask the Secretary of State for Health and Social Care, whether the National Institute for Health and Care Excellence has made a recent assessment of the potential impact of the removal of the end-of-life modifier on cancer technology appraisals.
Cancer: Medical Treatments
2 Sept 2024 · To ask the Secretary of State for Health and Social Care, how many myeloma patients are receiving a fourth line treatment; and what proportion of those patients are being treated with isatuximab in combination with pomalidomide and dexamethasone.
Respiratory Syncytial Virus: Vaccination
2 Sept 2024 · To ask the Secretary of State for Health and Social Care, what the evidential basis is for not extending the respiratory syncytial virus immunisation programme to all children under the age of one year.
NHS: Training
2 Sept 2024 · To ask the Secretary of State for Health and Social Care, how many applicants were (a) accepted onto and (b) rejected from the NHS Scientist Training Programme in (i) 2021-2022, (ii) 2022-2023 and (iii) 2023-2024.